Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

F N B Q4 Adj. EPS $0.30 Beats $0.29 Estimate

byBenzinga Newsdesk

January 21, 2020

1 minute read

F N B (NYSE:FNB) reported quarterly earnings of $0.3 per share which beat the analyst consensus estimate of $0.29 by 3.45 percent. This is unchanged from the same period last year.

News

Playboy Files For Trademark ‘CENTERFOLD’ Intended ‘to cover the categories of non fungible tokens’

By Bill Haddad

Today, 6:42 AM

https://uspto.report/TM/97318103

PLBY

Wells Fargo Maintains Equal-Weight on Illinois Tool Works, Raises Price Target to $223

By Benzinga Newsdesk

Today, 6:42 AM

Wells Fargo analyst Joseph O'Dea maintains Illinois Tool Works (NYSE:ITW) with a Equal-Weight and raises the price target from $219 to $223.

ITW

Bitcoin Crashing Below $30K Not Enough To Deter Cathie Wood — Ark Adds Another $31M In Coinbase, $3.4M In GBTC

By Rachit Vats

Today, 6:42 AM

Cathie Wood-led Ark Investment Management is ramping up cryptocurrency play even as the Bitcoin (CRYPTO: BTC) price plummeted

ARKF

News

Bloomberg Reported Earlier Novo Nordisk’s Obesity Drug Wegovy’s European Rollout Delayed After US Setbacks

By Charles Gross

Today, 6:42 AM

https://www.bloomberg.com/news/articles/2022-12-13/novo-nordisk-delays-europe-obesity-drug-rollout-to-ensure-supply

NVO

F N B Q4 Adj. EPS $0.30 Beats $0.29 Estimate

Related Posts

Playboy Files For Trademark ‘CENTERFOLD’ Intended ‘to cover the categories of non fungible tokens’

Wells Fargo Maintains Equal-Weight on Illinois Tool Works, Raises Price Target to $223

Bitcoin Crashing Below $30K Not Enough To Deter Cathie Wood — Ark Adds Another $31M In Coinbase, $3.4M In GBTC

Bloomberg Reported Earlier Novo Nordisk’s Obesity Drug Wegovy’s European Rollout Delayed After US Setbacks